Whitehawk Therapeutics Inc
NASDAQ:WHWKBiotechnology
+$0.06 today
- Market cap
- $184.70M
- Beta
- 0.77
- P/E (TTM)
- -2.6
- EPS (TTM)
- -$1.67
Volume 0.28M
Average 0.31M
WHWK Total Liabilities
Everything the company owes to creditors and other parties.
Whitehawk Therapeutics IncNASDAQ: WHWK
Total Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total liabilities falls 9.9% from a year ago
Total liabilities stood at $11.06M at the end of Q1 FY2026, down 9.9% from a year earlier and down 23.9% from the prior quarter. Over 3 fiscal years it compounded at -17.5% a year.
Context
- Total liabilities amounted to 8.7% of total assets at the end of Q1 FY2026, up 3.4 pp from a year earlier.
- Total liabilities increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps falling in the next quarterly balance sheet after a -9.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 14.52M USD
- Year-over-year change
- -18.6%
- 4-year CAGR
- -9.4%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 14.52M | -18.6% |
| FY2024 | 2024-12-31 | 17.84M | -34.5% |
| FY2023 | 2023-12-31 | 27.23M | +5.3% |
| FY2022 | 2022-12-31 | 25.86M | +20.3% |
| FY2021 | 2021-12-31 | 21.5M | — |
Total Liabilities vs competitors
How WHWK compares with its peers on the latest reported figures
- Peers report in different currencies, so total liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -9.9% is the 7th highest of 9, against a peer median of +16.7%.
- Total liabilities amounts to 8.7% of total assets for WHWK, versus a peer median of 23.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $196.68M USD | +35.2% | +10.9% | 90.3% | |
| Mar 2026 | $70.39M USD | -20.6% | -15.2% | 27.8% | |
| Mar 2026 | $40.47M USD | +33.6% | -4.7% | 186.8% | |
| Mar 2026 | $37.43M USD | -57.3% | +5.7% | 18.5% | |
| Mar 2026 | $27.36M USD | +22.3% | -4.1% | 12.1% | |
| Mar 2026 | CA$13.29M CAD | +0.6% | +13.0% | 162.9% | |
| Mar 2026 | $11.45M USD | +11.2% | +84.9% | 12.0% | |
WHWKWhitehawk Therapeutics Inc | Mar 2026 | $11.06M USD | -9.9% | -17.5% | 8.7% |
| Mar 2026 | $6.66M USD | +235.7% | +35.7% | 11.3% | |
| Peer median (excluding WHWK) | — | +16.7% | +8.3% | 23.1% | |
Competitors are the stored peer set for WHWK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 148.99M | 39.02M | 62.89M | 28.67M | 37.57M |
| Short-term Investments | 0 | 133.54M | 45.96M | 18.57M | 108.13M |
| Net Receivables | 0 | 1.86M | 5.49M | 5.9M | 0 |
| Inventory | 0 | 1.86M | 6.43M | 5.31M | 0 |
| Other Current Assets | 0 | 0 | 3.83M | 0 | 3.32M |
| Total Current Assets | 151.27M | 180.03M | 124.59M | 61.29M | 149.01M |
| Property, Plant & Equipment (Net) | 614K | 2.03M | 5.97M | 7.63M | 3K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 3.81M | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 2.21M | 2.18M | 1.87M | 1.4M | 1.81M |
| Total Non-current Assets | 6.64M | 4.21M | 7.84M | 9.03M | 1.82M |
| Total Assets | 157.91M | 184.24M | 132.42M | 70.32M | 150.83M |
| Account Payables | 6.44M | 3.52M | 5.9M | 2.16M | 917K |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.47M | 1.57M | 3.08M | 64K | 3.16M |
| Total Current Liabilities | 15.27M | 18.84M | 26.4M | 17.07M | 14.52M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 5.76M | 5.76M | 0 | 202K | 0 |
| Total Non-current Liabilities | 6.23M | 7.02M | 833K | 767K | 0 |
| Total Liabilities | 21.5M | 25.86M | 27.23M | 17.84M | 14.52M |
| Common Stock | 2K | 2K | 2K | 2K | 4K |
| Retained Earnings | (142.69M) | (203.2M) | (268.96M) | (332.65M) | (353.25M) |
| Accumulated OCI | 0 | (115K) | 27K | 16K | 120K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 136.41M | 158.38M | 105.2M | 52.48M | 136.31M |
| Total Debt | 605K | 1.66M | 1.27M | 833K | 0 |
| Net Debt | (148.38M) | (37.36M) | (61.62M) | (27.84M) | (37.57M) |
Whitehawk Therapeutics Inc
NASDAQ:WHWK
Intrinsic Alpha fair value
Locked
Current Price
$3.13
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.